Pfizer – Invasive Fungal Infections – RFP

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire within unit

Memorial Deadline: Thursday 1st, June 2023

External Deadline: Thursday 8th, June 2023


Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program

Date RFP Issued: May 4, 2023

Geographic Scope: Global excluding the United States

Clinical Area: Invasive Fungal Infections

Link to full RFP: Invasive Fungal Infections

Application Due Date: June 8, 2023

Specific Area of Interest: Potential applicants are encouraged to identify and address the educational needs of healthcare professionals to increase the awareness on early diagnosis of invasive molds and yeasts infections to improve the management of patients with IFI, address knowledge gaps in the testing and early diagnosis and treatment of IFI to ensure equitable access and improved patient outcomes, and increase the understanding of the risk factors associated with IFI.

Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Jessica Romano, Grant Officer (

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: May 4, 2023